​

Funding Round

Series A - Enlaza Therapeutics

Series A - Enlaza Therapeutics

Investment Firm

Overview

Enlaza Therapeutics is a biotechnology research company.

Announced Date

Apr 30, 2024

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

J.P. Morgan Asset Management

J.P. Morgan Asset Management

J.P. Morgan Asset Management is a late_stage_venture and private_equity firm.

Participant Investors

8

Investor Name
Participant InvestorPappas Capital
Participant InvestorAmgen Ventures
Participant InvestorRegeneron
Participant InvestorAvalon Ventures
Participant InvestorLightspeed Venture Partners

Round Details and Background

Enlaza Therapeutics raised $100000000 on 2024-04-30 in Series A

Enlaza Therapeutics is a biotechnology research company.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Oct 12, 2022
Seed Round - Enlaza Therapeutics
4-61.0M
Apr 30, 2024
Series A - Enlaza Therapeutics
10-100.0M
Mar 22, 2021
Seed Round - Enlaza Therapeutics
-4.0M

Recent Activity

There is no recent news or activity for this profile.